Money Matters - Simplified


Trading Up With the $95 From Genentech

Well, that was fast. Genentech finally agreed to be purchased by its majority shareholder, Roche, for $95 a share two weeks ago, and the deal has already closed.

You Are Right to Own This Stock

Here's a little tip most Wall Street types would prefer you not know: The recipe for great long-run success in the stock market is startlingly simple.

Better Than a Penny Stock

ACCC to take legal action against Telstra for network regulation breach

Melbourne, March 19: Australia’s competition watchdog is pursuing legal action against Telstra Corp for allegedly preventing rivals from accessing its network. The latest move has resulted in a serious blow to the shares of the phone company.

Tuesday's Biggest Stock Stars

Sirius Is a 5-Bagger

3 Stocks That Blew the Market Away

Pfizer Finally Gets a Hit!

5 Cash-Rich Companies at Bargain Prices

Freddie Mac: "Please, Sir, More Capital?"